论文部分内容阅读
目的:探讨小儿重症哮喘内科治疗临床效果。方法:本次共选择60例重症哮喘小儿作研究对象,均为我院儿科收治,随机分组就常规给氧,取氨茶碱(对照组)与加用沙丁胺醇联合布地奈德治疗(观察组)预后加以比较,回顾临床资料。结果:观察组选取病例临床总有效率为96.7%,明显高于对照组76.7%,差异有显著统计学意义(P<0.05)。观察组咳嗽缓解、哮鸣音消失、喘息缓解、住院天数明显少于对照组,差异均有统计学意义(P<0.05)。结论:小儿重症哮喘内科采用沙丁胺醇联合布地奈德治疗,可使临床症状及体征消除,缩短病程,改善预后,保障患儿生存质量。
Objective: To investigate the clinical effect of pediatric severe asthma medical treatment. Methods: A total of 60 children with severe asthma were enrolled in this study. All children were admitted to our hospital for pediatric treatment. The patients were randomly divided into two groups: conventional aminophylline (control group) plus salbutamol combined with budesonide (observation group) To compare the prognosis, review the clinical data. Results: The total clinical effective rate in the observation group was 96.7%, which was significantly higher than that in the control group (76.7%), the difference was statistically significant (P <0.05). The observation group cough relief, wheeze disappeared, wheezing relief, hospitalization days were significantly less than the control group, the difference was statistically significant (P <0.05). Conclusion: Salbutamol combined with budesonide in severe asthma pediatric patients can eliminate clinical symptoms and signs, shorten the course of disease, improve the prognosis and ensure the quality of life of children.